The Effects of Orchidectomy, Estrogens, and Cyproterone Acetate on Plasma Testosterone, LH, and FSH Concentrations in Patients with Carcinoma of the Prostate

REFERENCES

• Baker, H. W. G., Burger, H. G., de Kretser, D. M., Hudson, B., Rennie, G. C. & Stratton, W. G. 1975. The assessment of results following endocrine therapy for prostatic cancer. J Urol 113, 824.
   PubMed Web of Science ®Google Scholar
• Bartsch, W., Horst, H.-J., Becker, H. & Nehse, G. 1977. Sex hormone binding globulin capacity, testosterone, 5α-dihydrotestosterone, oestradiol and prolactin in plasma of patients with prostatic carcinoma under various types of hormonal treatment. Acta Endocrinol (Kbh)85, 650.
   Google Scholar
• Beck, P. H., McAninch, J. W., Goebel, J. L. & Stutzman, R. E. 1978. Plasma testosterone in patients receiving diethylstilbestrol. Urology 11 (2), 157.
   PubMedGoogle Scholar
• Bracci, U., Di Silverio, F., Sciarra, R., Sorcini, G., Piro, C. & Santoro, F. 1977. Hormonal pattern in prostatic carcinoma following orchidectomy. 5-Year follow-up. Br J Urol 49, 161.
   PubMedGoogle Scholar
• Bracci, U. 1979. Antiandrogens in the treatment of prostatic cancer. Eur Urol 5, 303.
   PubMed Web of Science ®Google Scholar
• Breuer, H. & Hoffman, W. 1967. The effect of cyproterone acetate on the biogenesis of testosterone and related compounds. In Testosterone. Proceedings, of a Workshop Conference (ed. J.Tamm), pp. 162–167. Georg Thieme Verlag, Stuttgart (Publ. 1968).
   Google Scholar
• Brotherton, J. & Barnard, G. 1974. Some aspects of the effect of cyproterone acetate on levels of other steroid hormones in man. J Reprod Fertil 36, 373.
   PubMedGoogle Scholar
• Byar, D. P. 1973. The Veterans Administration Cooperative Urological Research Group's Studies of cancer of the prostate. Cancer 32, 1126.
   PubMed Web of Science ®Google Scholar
• Clark, P. & Houghton, L. 1977. Subcapsular orchidectomy for carcinoma of the prostate. Br J Urol 49, 419.
   PubMedGoogle Scholar
• Engel, K. & Karsznia, R. 1971. Effect of cyproterone acetate on the testosterone biosynthesis in rat testes. Hoppe-Seylers Z Physiol Chem 352, 559.
   PubMedGoogle Scholar
• Fang, S. & Liao, S. 1969. Antagonistic action of antiandrogens on the formation of a specific dihydro-testosterone receptor protein complex in rat central prostate. Mol Pharmacol 5, 428.
   PubMed Web of Science ®Google Scholar
• Feldman, H. & Rodbard, D. 1971. Mathemathical theory of radioimmunoassay. In Principles of competitive protein binding assays (ed. W. D.Odell & W. H.Daughaday), pp. 158–203. J. Lippincott & Co, Philadelphia, Toronto.
   Google Scholar
• Fosså, S. D., Fosså, J. & Aakvaag, A. 1977. Hormone changes in patients with prostatic carcinoma during treatment with estramustine phosphate. J Urol 118, 1013.
   PubMed Web of Science ®Google Scholar
• Fukutani, K., Isurugi, K., Ishida, H. & Yokoyama, M. 1979. Effects of estrogens on the testosterone levels of peripheral and spermatic vein blood in patients with prostatic cancer. J Urol 122, 624.
   PubMed Web of Science ®Google Scholar
• Geller, J., Fishman, J. & Cantor, T. L. 1975. Effect of cyproterone acetate on clinical, endocrine and pathological features of benign prostatic hypertrophy. J Steroid Biochem 6, 837.
   PubMedGoogle Scholar
• Ghandian, R., O'Donoghue, E. P. N. & Puah, C. M. 1979. Changes in dihydrotestosterone and testosterone following endocrine manipulation in carcinoma of the prostate. Cancer Treat Rep 63 (7), 1192.
   Google Scholar
• Gräf, K.-J., Brotherton, J. & Neumann, F. 1974. Clinical uses of antiandrogens. In Handbook of epxerimental pharmacology, vol. 35/2, pp. 1–11. Springer-Verlag, Berlin, Heidelberg, New York.
   Google Scholar
• Gupta, D., Jacobi, G. H., Blank, B. & Altwein, J. E. 1979. Androgens and sexhormone binding globulin (SHBG) in subjects with prostatic carcinoma and BPH. Cancer Treat Rep 63 (7), 1154.
   Google Scholar
• Hammond, G. L., Kontturi, M., Vihko, P. & Vihko, R. 1978. Serum steroids in normal males and patients with prostatic diseases. Clin Endocrinol 9, 113.
   PubMed Web of Science ®Google Scholar
• Harper, M. E., Peeling, N. B., Cowley, T., Brownsey, B. C., Phillips, M. E. A., Groom, G., Fahmy, D. R. & Griffiths, K. 1976. Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during oestrogen therapy. Acta Endocrinol (Kbh) 81, 409.
   PubMedGoogle Scholar
• Houghton, A. L. & Jacobs, H. S. 1978. Advanced carcinoma of the prostate: Does the pre-treatment Leydig cell function determine the response to orchidectomy? Postgrad Med J 54, 261.
   PubMed Web of Science ®Google Scholar
• Huggins, C. & Hodges, C. V. 1941. Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1, 293.
   Google Scholar
• Huggins, C., Stevens, R. E. & Hodges, C. V. 1941. Studies on prostatic cancer. II. The effects of castration on advanced carcinoma of the prostate gland. Arch Surg 43, 209.
   Google Scholar
• Jönsson, G., Olsson, A. M., Luttrop, W., Cekan, Z., Purvis, K. & Diczfalusy, E. 1975. Treatment of prostatic carcinoma with various types of estrogen derivatives. Vitam Horm 33, 351.
   PubMedGoogle Scholar
• Kaartinen, E., Laukkanen, M. & Saure, A. 1971. Metabolism of dehydroepiandrosterone by rat testicular homogenates: kinetic study at different temperatures; direct effect of 17β-estradiol. Acta Endocrinol (Kbh) 66, 50.
   PubMedGoogle Scholar
• Lagrelius, A., Carlström, K. & Lunell, N-D. 1981. Treatment with oral estrone sulphate in the female climacteric. II. Hormonal aspects. Acta Obstet Gynecol Scand 60, 33.
   PubMed Web of Science ®Google Scholar
• Mawhinney, M. G. & Neubauer, B. L. 1979. Actions of estrogen in the male. Invest Urol 16, 409.
   PubMedGoogle Scholar
• Morse, H. C., Leach, D. R., Rowley, M. J. & Heller, C. G. 1975. Effect of cyproterone acetate on sperm concentration, seminal fluid volume, testicular cytology and levels of plasma and urinary ICSH, FSH and testosterone in normal men. J Reprod Fert 32 (3), 365.
   Google Scholar
• Murono, P. E. & Payne, A. H. 1976. Distinct testicular 17-ketosteroid reductases, one in interstitial tissue and one in seminiferous tubules. Differential modulation by testosterone and metabolites of testosterone. Biochim Biophys Acta 450, 89.
   PubMedGoogle Scholar
• Murray, M. A. F., Anderson, D. C., Bancroft, J. H. J., Tennant, T. G. & Carr, P. J. 1973. Sex-hormonebinding globulin, luteinizing hormone and testosterone in man: Effects of oestrogen and cyproterone acetate. J Endocrinol 59, XXI-XXII.
   PubMed Web of Science ®Google Scholar
• Neumann, F., v. Berswordt-Wallrabe, R., Elger, W., Steinbeck, H., Hahn, J. D. & Kramer, M. 1970. Aspects of androgen-dependent events as studied by antiandrogens. Recent Progr Hormone Res 26, 337.
   PubMedGoogle Scholar
• Robinson, M. R. G. & Thomas, E. S. 1971. Effect of hormonal therapy on plasma testosterone levels in prostatic carcinoma. Br Med J 3, 391.
   PubMedGoogle Scholar
• Sanfort, E. J., Paulson, D. F., Rohner, T. J., Drage, J. R., Santen, R. J. & Bardin, C. W. 1977. The effect of castration on adrenal testosterone secretion in men with prostatic carcinoma. J Urol 118, 1019.
   PubMed Web of Science ®Google Scholar
• Sanwal, P. C., Sundby, A. & Edqvist, L. E. 1974. Diurnal variations of peripheral plasma levels of testosterone in bulls measured by a rapid radioimmunoassay procedure. Acta Vet Scand 15, 90.
   PubMed Web of Science ®Google Scholar
• Schoonees, R., Schalch, D. S. & Murphy, P. 1971. The hormonal effects of antiandrogen (SH-714) treatment in man. Invest Urol 8, 635.
   PubMedGoogle Scholar
• Sciarra, F., Sorcini, G., di Silverio, F. & Gogliardi, V. 1973. Plasma testosterone and androstenedione after orchidectomy in prostatic adenocarcinoma. Clin Endocrinol 2, 101.
   PubMedGoogle Scholar
• Shearer, R. J., Hendry, W. F., Sommerville, I. F. & Fergusson, J. D. 1973. Plasma testosterone: An accurate monitor of hormone treatment in prostatic cancer. Br J Urol 45, 668.
   PubMedGoogle Scholar
• Sköldefors, H., Carlström, K. & Eneroth, P. 1978. Influence of aging upon the serum hormone levels in the male. Int J Andr l, 308.
   Google Scholar
• Smith, R. B., Walsh, P. C. & Goodwin, W. E. 1973. Cyproterone acetate in the treatment of advanced carcinoma of the prostate. J Urol 110, 106.
   PubMed Web of Science ®Google Scholar
• Tveter, K. J., Attramadal, A., Aakvaag, A. & Hansson, V. 1971. Androgenic receptors in rat and human prostate. Advanced in Bioscience 7, 193.
   Google Scholar
• Union Internationale Contre le Cancrum, TNM classification of malignant tumours, Geneva, 1978.
   Google Scholar
• Wein, A. J. & Murphy, J. J. 1973. Experience in the treatment of prostatic carcinoma with cyproterone acetate, J Urol 109, 68.
   PubMed Web of Science ®Google Scholar
• Veterans Administration Cooperative Urological Research Group. Treatment and survival of patients with cancer of the prostate. Surg Gyn Obstet 124, 1011, 1967.
   PubMedGoogle Scholar
• Weidner, W., Krause, W., Pust, R., Engstfeld, J. & Rothauge, C. F. 1978. Testosteron, FSH- und LH-Spiegel im Serum bei Patienten mit Prostatakarzinom unter Behandlung mit weiblichen Hormonen. Helv Chir acta 45, 287.
   PubMedGoogle Scholar
• Zumoff, B., Rosenfeld, R. S., O'Connor, J. F. & Fukushima, D. K. 1979. Abnormal plasma hormone levels in prostate cancer. Cancer Treat Rep 63, 1154.
   Google Scholar